<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01634607</url>
  </required_header>
  <id_info>
    <org_study_id>TNT-HIV 003.1</org_study_id>
    <nct_id>NCT01634607</nct_id>
  </id_info>
  <brief_title>Bone Health and Vitamin D Status</brief_title>
  <acronym>BHVD</acronym>
  <official_title>Bone Health and Vitamin D Status in Thai HIV-1 Infected and Uninfected Adults (A Substudy of TNT-HIV 003: Trends of Morbidity and Mortality Among Thai HIV-infected and HIV-uninfected Patients: a Five-year Prospective Cohort Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Thai Red Cross AIDS Research Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ViiV Healthcare</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>HIV Netherlands Australia Thailand Research Collaboration</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bamrasnaradura Infectious Diseases Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Thai Red Cross AIDS Research Centre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will compare and assess the prevalence of osteopenia and vitamin D deficiency as
      well as effects of TDF on the patients' bone among HIV positive and negative patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To determine the prevalence of osteopenia and vitamin D deficiency in HIV-1 infected, HAART
      naive Thai patients compared to HIV-1 uninfected Thai participants. Furthermore, to determine
      the change in BMD after twelve months in HIV-1 infected Thai patients on a TDF-based HAART
      regimen compared to patients on a non-TDF containing regimen.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>October 2010</start_date>
  <completion_date type="Anticipated">October 2020</completion_date>
  <primary_completion_date type="Anticipated">October 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>osteopenia</measure>
    <time_frame>60 months</time_frame>
    <description>development of osteopenia</description>
  </primary_outcome>
  <primary_outcome>
    <measure>vitamin D deficiency</measure>
    <time_frame>60 months</time_frame>
    <description>development of vitamin D deficiency</description>
  </primary_outcome>
  <primary_outcome>
    <measure>BMD</measure>
    <time_frame>1 year</time_frame>
    <description>changes of BMD</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">235</enrollment>
  <condition>Osteopenia</condition>
  <condition>Vitamin D Deficiency</condition>
  <condition>HIV Infection</condition>
  <arm_group>
    <arm_group_label>HIV uninfected</arm_group_label>
    <description>HIV negative patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HIV-infected, HAART naïve, high CD4 count</arm_group_label>
    <description>HIV positive patients with high CD4 and not on HIV treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HIV-infected with planned to start HAART group</arm_group_label>
    <description>HIV positive patients who will start HIV treatment</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        All participants are from the Anonymous Clinic of the Thai Red Cross AIDS Research Centre
        (TRC-ARC, the HIV Netherlands Australia Thailand Research Collaboration (HIVNAT) and Queen
        Savang Vadhana Memorial Hospital (QSV).
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  HIV uninfected:

               -  HIV negative confirmed by HIV testing

               -  Age 30 years and older

               -  Thai nationality

               -  Signed informed consent form for the study

          -  HIV-infected, HAART naïve:

               -  Recorded HIV infection

               -  Age 30 years and older

               -  Thai nationality

               -  Signed informed consent form for the study

          -  HIV-infected, HAART group:

               -  Recorded HIV infection

               -  Age 30 years and older

               -  Thai nationality

               -  HAART naïve at baseline, planned to start HAART within 90 days. Past exposure to
                  antiretroviral therapy during pregnancy for the prevention of mother to child
                  transmission of HIV ≥ 3 months prior to screening will be allowed

               -  Signed informed consent form for the study

        Exclusion Criteria:

          -  HIV uninfected

               -  Currently pregnant or lactating

               -  Recent hospitalization

               -  Use of anticonvulsants, steroids or vitamin D supplements

          -  HIV-infected, HAART naïve

               -  CD4 &lt; 350

               -  Currently pregnant/lactating

               -  Recent hospitalization

               -  Signs of wasting

               -  Use of anticonvulsants, steroids or vitamin D supplements

          -  HIV-infected, HAART group:

               -  Prior antiretroviral therapy use

               -  Currently pregnant/lactating

               -  Recent hospitalization

               -  Signs of wasting

               -  Active opportunistic infection

               -  Use of anticonvulsants, steroids or vitamin D supplements
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Praphan Phanuphak, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Thai Red Cross AIDS Research Centre</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Thai Red Cross AIDS Research Centre</name>
      <address>
        <city>Pathum Wan</city>
        <state>Bangkok</state>
        <zip>10330</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 2, 2012</study_first_submitted>
  <study_first_submitted_qc>July 5, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 6, 2012</study_first_posted>
  <last_update_submitted>April 18, 2018</last_update_submitted>
  <last_update_submitted_qc>April 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>osteopenia</keyword>
  <keyword>vitamin D deficiency</keyword>
  <keyword>HIV-infected patients</keyword>
  <keyword>bone health</keyword>
  <keyword>Bone mineral density (BMD)</keyword>
  <keyword>HIV-uninfected patients</keyword>
  <keyword>effects of TDF on the patients' bone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>HIV Infections</mesh_term>
    <mesh_term>Vitamin D Deficiency</mesh_term>
    <mesh_term>Bone Diseases, Metabolic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

